PHARMACEUTICAL PREPARATIONS AND THEIR USING FOR PROPHYLAXIS OF STROKE, DIABETES AND/OR CONGESTIVE CARDIAC INSUFFICIENCY Russian patent published in 2006 - IPC A61K45/06 A61K31/401 A61K31/4178 A61P3/10 A61P9/10 

Abstract RU 2272651 C2

FIELD: medicine, pharmacy.

SUBSTANCE: invention proposes a pharmaceutical preparation based on angiotensin-converting enzyme inhibitor, its using in prophylaxis of insult, diabetes and/or congestive cardiac insufficiency and corresponding methods for its using in patient with maintenance heart function and subjected for risk of cardiovascular attack due to previous history of ischemic disease, insult or peripheral arterial disease. In particular, inhibitor of angiotensin-converting enzyme can be chosen from ramipril, ramiprilat, lisinopril, enalapril and enalaprilat. Invention promotes to reducing the total lethality of patients group in case of cardiovascular diseases, cardiac attacks and insults, the necessity for carrying out procedures for revascularization (such as surgery operation for coronary shunt, angioplasty with using balloon and so on) and diabetic complication are diminished.

EFFECT: improved and valuable medicinal properties of preparations.

19 cl, 1 ex

Similar patents RU2272651C2

Title Year Author Number
PHARMACEUTICAL PREPARATIONS AND THEIR APPLICATION FOR PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE 2005
  • Shelkens Bernvard
  • Bender Norbert
  • Rangoonvala Badrudin
  • Dazhene Zhill'
  • Gershtajn Kherttsel'
  • Junggren Anders
  • Jusuf Salim
RU2378018C2
NEW MEDICINAL APPLICATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACEI) IN TREATING DYSPEPTIC SYMPTOMS 1996
  • Fendriks Lars
  • Pettersson Anders
RU2203092C2
RENIN-ANGIOTENSIN SYSTEM INHIBITORS APPLICATION FOR PREVENTING CARDIOVASCULAR DISEASE MANIFESTATIONS 2000
  • Shelkens Bernvard
  • Bender Norbert
  • Rangoonvala Badrudin
  • Jusuf Salim
  • Dazhene Zhill'
  • Gershtajn Kherttsel'
RU2276997C2
DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTORS ACTIVATED BY PEROXISOME PROLIFERATOR (PPARα), METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR TREATMENT OF DYSLIPIDEMIA IN DIABETES MELLITUS TYPE 2 2002
  • Al'Stermark Lindstedt Ehva-Lotte
  • Ol'Sson Anna Kristina
  • Li Lanna
RU2303031C2
DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTOR (PPARα) ACTIVATED BY PEROXISOME PROLIFERATORS, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR DYSLIPIDEMIA TREATMENT AND TYPE 2 DIABETES MELLITUS 2002
  • Al'Stermark Lindstedt Ehva-Lotte
  • Ol'Sson Anna Kristina
  • Li Lanna
RU2300517C2
NEBIVOLOL-INCLUDING COMPOSITIONS 2005
  • Dehvis Ehrik
  • O'Donnell Dzhon
  • Bottini Piter Brjus
RU2403037C2
COMBINATION OF DIPEPTIDILPEPTIDASE IV (DPP IV) INHIBITOR AND CARDIOVASCULAR SUBSTANCE 2003
  • Olme David Grenvill'
  • Shetti Suraj Shivappa
  • Kh'Juz Tomas Ehduard
RU2336876C2
APPLICATION OF ANGIOTENSIN II RECEPTOR ANTAGONISTS FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION 2006
  • Mann Essika M.
  • Oddu Paskal'
  • Nehar Ehrik Mishel'
RU2345790C2
APPLICATION OF ORGANIC COMPOUNDS 2005
  • Feldman Dejvid Luis
  • Zelenkofske Stiven
  • Dinbbek Mikhaehla
  • Preskott Margaret Forni
RU2426532C2
COMBINATION OF AT LEAST TWO COMPOUNDS CHOSEN FROM GROUPS AT-RECEPTOR ANTAGONISTS OR INHIBITORS OF ACE (ANGIOTENSIN-CONVERTING ENZYME) OR INHIBITORS OF HMG-COA-REDUCTASE (BETA-HYDROXY-BETA-METHYLGLUTARYL-COENZYME-A-REDUCTASE) 2001
  • De-Gasparo Mark
  • Grejvz Kurt S.
RU2298418C2

RU 2 272 651 C2

Authors

Shelkens Bernvard

Bender Norbert

Rangoonvala Badrudin

Dazhene Zhill'

Gershtajn Kherttsel'

Junggren Anders

Jusuf Salim

Dates

2006-03-27Published

2000-08-25Filed